Sharekhan is bullish on Strides Pharma Sciences has recommended buy rating on the stock with a target price of Rs 1874 in its research report dated October 24, 2024.

Buy Strides Pharma Science; target of Rs 800: Sharekhan

Sharekhan is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 800 in its research report dated January 30, 2024.

Accumulate Strides Pharma Science; target of Rs 731: Geojit

Geojit recommended accumulate rating on Strides Pharma Science with a target price of Rs 731 in its research report dated December 26, 2023.

Reduce Strides Pharma Science; target of Rs 495: ICICI Securities

ICICI Securities recommended reduce rating on Strides Pharma Science with a target price of Rs 495 in its research report dated September 26, 2023.

Hold Strides Pharma Science; target of Rs 600: Sharekhan

Sharekhan recommended Hold rating on Strides Pharma Science with a target price of Rs 600 in its research report dated September 26, 2023.

Hold Strides Pharma Sciences; target of Rs 491: Sharekhan

Sharekhan recommended Hold rating on Strides Pharma Sciences with a target price of Rs 491 in its research report dated August 02, 2023.

Buy Strides Pharma Sciences; target of Rs 450: Sharekhan

Sharekhan is bullish on Strides Pharma Sciences Ltd has recommended buy rating on the stock with a target price of Rs 450 in its research report dated June 01, 2023.

Buy Strides Pharma Sciences, target of Rs 450: Sharekhan

Sharekhan is bullish on Strides Pharma Sciences has recommended buy rating on the stock with a target price of Rs 450 in its research report dated January 25, 2023.

Buy Strides Pharma Sciences; target of Rs 450: Sharekhan

Sharekhan is bullish on Strides Pharma Sciences has recommended buy rating on the stock with a target price of Rs 450 in its research report dated November 15, 2022.

Buy Strides Pharma Sciences; target of Rs 450: Sharekhan

Sharekhan is bullish on Strides Pharma Sciences has recommended buy rating on the stock with a target price of Rs 450 in its research report dated July 29, 2022.

Accumulate Strides Pharma Science; target of Rs 355: Geojit

Geojit recommended accumulate rating on Strides Pharma Science with a target price of Rs 355 in its research report dated June 23, 2022.

Buy Strides Pharma Science; target of Rs 936: Geojit

Geojit is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 936 in its research report dated June 03, 2021.

Buy Strides Pharma; target of Rs 930: Motilal Oswal

Motilal Oswal is bullish on Strides Pharma recommended buy rating on the stock with a target price of Rs 930 in its research report dated May 28, 2021.

Buy Strides Pharma Science; target of Rs 1020: Sharekhan

Sharekhan is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 1020 in its research report dated February 04, 2021.

Lupin: New launches and market share gains are likely to override pricing erosion

New launches in the US, particularly in the inhalation category, and an improving market share are expected to help ride over structural pricing erosion in the near term for Lupin

Buy Strides Pharma Sciences; target of Rs 864: Sharekhan

Sharekhan is bullish on Strides Pharma Sciences recommended buy rating on the stock with a target price of Rs 864 in its research report dated October 29, 2020.

Buy Strides Pharma Science: target of Rs 710: ICICI Securities

ICICI Securities is bullish on Strides Pharma Science recommended buy rating on the stock with a target price of Rs 710 in its research report dated September 03, 2020.

Accumulate Strides Pharma Science; target of Rs 621: Geojit

Geojit recommended accumulate rating on Strides Pharma Science with a target price of Rs 621 in its research report dated August 07, 2020.

Buy Strides Pharma; target of Rs 650: Motilal Oswal

Motilal Oswal is bullish on Strides Pharma recommended buy rating on the stock with a target price of Rs 650 in its research report dated August 06, 2020.

Buy Strides Pharma Science; target of Rs 421: ICICI Securities

ICICI Securities is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 421 in its research report dated May 21, 2020.

Buy Strides Pharma; target of Rs 635: Motilal Oswal

Motilal Oswal is bullish on Strides Pharma has recommended buy rating on the stock with a target price of Rs 635 in its research report dated May 11, 2019.

Buy Strides Pharma Science; target of Rs 530: Geojit

Geojit is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 530 in its research report dated January 31, 2019.

Buy Strides Pharma; target of Rs 590: Motilal Oswal

Motilal Oswal is bullish on Strides Pharma has recommended buy rating on the stock with a target price of Rs 590 in its research report dated January 29, 2019.